Legal Representation
Attorney
Ilene B Tannen
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 13, 2002 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jan 29, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 6, 2001 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 17, 2001 | NPUB | O | NOTICE OF PUBLICATION |
| Apr 18, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 6, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 30, 2001 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 28, 2001 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 001
oligonucleotides for introducing site specific mutations in a cell for scientific or medical research use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
oligonucleotides for introducing site specific mutations in a cell for the therapeutic use
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
manufacture of oligonucleotides for introducing site specific mutations in a cell made to the order and specifications of others
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
040